Market Place
Sourcing Support
All News #Library
Biotech
Akebia Announces 1st Participants Dosed in Ph 1 Trial of AKB-9090
13 Apr 2026 //
GLOBENEWSWIRE
Akebia Therapeutics to Attend Raymond James 2026 Biotech
07 Apr 2026 //
GLOBENEWSWIRE
Akebia Therapeutics Hosts Kidney R&D Day on April 2, 2026
19 Mar 2026 //
GLOBENEWSWIRE
Akebia Therapeutics To Present At Guggenheim Biotech Summit 2026
04 Feb 2026 //
GLOBENEWSWIRE
Akebia Pharma Reveals Corporate Updates And 2026 Pipeline
12 Jan 2026 //
GLOBENEWSWIRE
Akebia Doses First Patient in Phase 2 FSGS Trial of Praliciguat
06 Jan 2026 //
GLOBENEWSWIRE
Akebia to Present at 37th Piper Sandler Healthcare Conference
24 Nov 2025 //
GLOBENEWSWIRE
Vafseo Shows Better Outcomes In Dialysis Patients Vs. ESAs
06 Nov 2025 //
GLOBENEWSWIRE
Akebia Therapeutics To Present At Upcoming Investor Conferences
04 Nov 2025 //
GLOBENEWSWIRE
Akebia Provide Updates on Vafseo For Non-Dialysis Patients
28 Oct 2025 //
GLOBENEWSWIRE
Akebia Pharma Reveals 5 Presentations At ASN Kidney Week 2025
20 Oct 2025 //
GLOBENEWSWIRE
Akebia Therapeutics Discloses Inducement Grants Per Nasdaq LR
01 Oct 2025 //
GLOBENEWSWIRE
Akebia Therapeutics issues inducement Grants per Nasdaq Rule
01 Aug 2025 //
GLOBENEWSWIRE
Krystal Biotech raises $160M via PIPE on heels of FDA approval for gene therapy
22 May 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.